Overview

Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes

Status:
Terminated
Trial end date:
2008-03-11
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). This trial will compare the changes in HbA1c after 26 weeks of inhaled insulin or rosiglitazone treatment, both in combination with metformin and glimepiride.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Glimepiride
Insulin
Insulin, Globin Zinc
Metformin
Rosiglitazone